| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.69▼ | 5.69▼ | 5.70▼ | 5.68▲ | 5.67▲ |
| MA10 | 5.69▼ | 5.70▼ | 5.69▲ | 5.69▲ | 5.58▲ |
| MA20 | 5.70▼ | 5.69▲ | 5.68▲ | 5.67▲ | 5.46▲ |
| MA50 | 5.68▲ | 5.70▼ | 5.69▼ | 5.55▲ | 5.25▲ |
| MA100 | 5.70▼ | 5.69▼ | 5.67▲ | 5.42▲ | 5.15▲ |
| MA200 | 5.68▲ | 5.63▲ | 5.59▲ | 5.24▲ | 5.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.001▲ | 0.002▲ | -0.007▼ | 0.025▲ |
| RSI | 47.934▼ | 49.618▼ | 50.545▲ | 59.831▲ | 64.584▲ |
| STOCH | 8.333▼ | 38.757 | 58.862 | 62.121 | 87.403▲ |
| WILL %R | -100.000▼ | -57.143 | -57.143 | -27.273 | -13.953▲ |
| CCI | -59.682 | 5.469 | 20.144 | 47.519 | 114.806▲ |
| MA | $GLO Price Crossed Above MA(7) | Set Alert |
|
Tuesday, September 30, 2025 05:56 AM
New data in human cancer cell lines provides confirmation of pan-KRAS mutation inhibition with inhibition of G12D, G12V, G12R, G12C, G13C, G12A, Q61H, and G13D mutations Company Reports first evidence ...
|
|
Tuesday, September 30, 2025 05:50 AM
Silexion Therapeutics (SLXN) announced that SIL204 has demonstrated activity against eleven human cell lines originating from ...
|
|
Tuesday, September 30, 2025 05:48 AM
New data in human cancer cell lines provides confirmation of pan-KRAS mutation inhibition with inhibition of G12D, G12V, G12R, G12C, G13C, G12A, Q61H, and G13D mutations Company Reports first evidence ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 5.67 | 5.74 | 5.67 | 5.70 | 166,100 |
| 29/09/25 | 5.68 | 5.71 | 5.66 | 5.69 | 96,500 |
| 26/09/25 | 5.66 | 5.70 | 5.66 | 5.66 | 46,900 |
| 25/09/25 | 5.68 | 5.69 | 5.65 | 5.65 | 116,400 |
| 24/09/25 | 5.74 | 5.74 | 5.70 | 5.71 | 119,100 |
| 23/09/25 | 5.73 | 5.74 | 5.69 | 5.71 | 178,900 |
| 22/09/25 | 5.70 | 5.76 | 5.69 | 5.73 | 136,000 |
| 19/09/25 | 5.75 | 5.75 | 5.66 | 5.72 | 129,600 |
| 18/09/25 | 5.67 | 5.72 | 5.66 | 5.71 | 115,400 |
| 17/09/25 | 5.59 | 5.70 | 5.54 | 5.64 | 408,400 |
|
|
||||
|
|
||||
|
|